These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2127155)

  • 1. Lithium discontinuers. I. Clinical characteristics and outcome.
    Nilsson A; Axelsson R
    Acta Psychiatr Scand; 1990 Dec; 82(6):433-8. PubMed ID: 2127155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium discontinuers. II. Therapeutic outcome.
    Nilsson A; Axelsson R
    Acta Psychiatr Scand; 1991 Jul; 84(1):78-82. PubMed ID: 1681682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of lithium in prophylaxis of unipolar depression Evidence from its discontinuation.
    Souza FG; Mander AJ; Goodwin GM
    Br J Psychiatry; 1990 Nov; 157():718-22. PubMed ID: 2279209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopathology during long-term lithium treatment of patients with major affective disorders. A prospective study.
    Nilsson A; Axelsson R
    Acta Psychiatr Scand; 1989 Oct; 80(4):375-88. PubMed ID: 2511737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with discontinuation of long-term lithium treatment.
    Nilsson A; Axelsson R
    Acta Psychiatr Scand; 1989 Sep; 80(3):221-30. PubMed ID: 2510458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study.
    Strober M; Morrell W; Lampert C; Burroughs J
    Am J Psychiatry; 1990 Apr; 147(4):457-61. PubMed ID: 2107763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance during lithium treatment, intra-erythrocyte lithium variability, and relapse.
    Harvey NS; Kay R
    J Clin Psychopharmacol; 1991 Dec; 11(6):362-7. PubMed ID: 1770155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination tricyclic antidepressant and lithium maintenance medication in unipolar and bipolar depressed patients.
    Johnstone EC; Owens DG; Lambert MT; Crow TJ; Frith CD; Done DJ
    J Affect Disord; 1990 Dec; 20(4):225-33. PubMed ID: 2149728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders.
    Baldessarini RJ; Tondo L; Hennen J
    J Clin Psychiatry; 1999; 60 Suppl 2():77-84; discussion 111-6. PubMed ID: 10073392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years.
    Berghöfer A; Kossmann B; Müller-Oerlinghausen B
    Acta Psychiatr Scand; 1996 May; 93(5):349-54. PubMed ID: 8792904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a lithium withdrawal syndrome? An examination of the evidence.
    Schou M
    Br J Psychiatry; 1993 Oct; 163():514-8. PubMed ID: 8252292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders.
    Maj M; Pirozzi R; Kemali D
    Psychopharmacology (Berl); 1989; 98(4):535-8. PubMed ID: 2505295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.
    Viguera AC; Whitfield T; Baldessarini RJ; Newport DJ; Stowe Z; Reminick A; Zurick A; Cohen LS
    Am J Psychiatry; 2007 Dec; 164(12):1817-24; quiz 1923. PubMed ID: 18056236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.
    Goodwin GM
    Br J Psychiatry; 1994 Feb; 164(2):149-52. PubMed ID: 8173817
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum and red cell folate and affective morbidity in lithium prophylaxis.
    McKeon P; Shelley R; O'Regan S; O'Broin J
    Acta Psychiatr Scand; 1991 Mar; 83(3):199-201. PubMed ID: 2031463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium discontinuation: uncovering latent bipolar disorder?
    Faedda GL; Tondo L; Baldessarini RJ
    Am J Psychiatry; 2001 Aug; 158(8):1337-9. PubMed ID: 11481189
    [No Abstract]   [Full Text] [Related]  

  • 17. Carbamazepine prophylaxis in refractory affective disorders: a focus on long-term follow-up.
    Post RM; Leverich GS; Rosoff AS; Altshuler LL
    J Clin Psychopharmacol; 1990 Oct; 10(5):318-27. PubMed ID: 2124216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium prophylaxis of bipolar illness. The value of combination treatment.
    Peselow ED; Fieve RR; Difiglia C; Sanfilipo MP
    Br J Psychiatry; 1994 Feb; 164(2):208-14. PubMed ID: 7909713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium prophylaxis of manic-depressive disorder: daily lithium dosing schedule versus every second day.
    Jensen HV; Plenge P; Mellerup ET; Davidsen K; Toftegaard L; Aggernaes H; Bjørum N
    Acta Psychiatr Scand; 1995 Jul; 92(1):69-74. PubMed ID: 7572251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.